Security key
85209E208
SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB)
CUSIP: 85209E208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,373,497
- Total 13F shares
- 2,937,895
- Share change
- +2,937,895
- Total reported value
- $25,135,295
- Price per share
- $8.95
- Number of holders
- 9
- Value change
- +$25,135,295
- Number of buys
- 9
Report period
Q3 2025
Institutions
9
Top holders
9
SPRB full security history
Newer quarter: Q4 2025
SPRUCE BIOSCIENCES, INC. SEC filings
SPRUCE BIOSCIENCES, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 85209E208
Recent filing periods:
Top shareholders of SPRB - SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RiverVest Venture Fund III, L.P. |
13D/G
|
John P. McKearn, Ph.D. |
4.2%
|
1,759,521
|
$140,762 | $0 | 07 Jan 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
76%
|
1,045,828
|
$74,000 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
73%
|
1,000,000
|
$72,501 | — | 30 Jun 2025 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0.07%
|
1,000
|
$73 | — | 30 Jun 2025 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,550,000
|
$1,924,485 | — | 21 Mar 2024 | |
| Ralph William Charlton III |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
224,839
mixed-class rows
|
$87,394 | — | 10 Dec 2024 | |
| Subaweerage Dias |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
95,000
mixed-class rows
|
$33,200 | — | 16 Dec 2021 | |
| Richard King |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
2,230
|
$2,180 | — | 30 Jun 2021 | |
| Bali Muralidhar |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 22 Jul 2025 | |
| Niall O'Donnell |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 25 May 2023 | |
| Tiba Aynechi |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 22 Jul 2025 | |
| Moghrabi Dina Chaya |
3/4/5
|
Director |
—
class O/S missing
|
22,500
|
— | — | 25 May 2022 |
Institutional Holders of SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) as of Q3 2025
As of 30 Sep 2025,
SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,937,895 shares.
The largest 9 holders included
Carlyle Group Inc., Cable Car Capital, LP, Ikarian Capital, LLC, Lion Point Capital, LP, OSAIC HOLDINGS, INC., UBS Group AG, MORGAN STANLEY, CALDWELL SUTTER CAPITAL, INC., and BANK OF AMERICA CORP /DE/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q4 2025 Across Filers
Q4 2025 holders
32
Q3 2025 holders
9
Holder diff
-23
| Investor | Q4 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.